CAM Labs' Use Of Unestablished Tests Largely Unregulated, HHS IG Reports
This article was originally published in The Tan Sheet
Executive Summary
Complementary and alternative medicine laboratories practicing live blood cell analysis (LBA) and other unestablished diagnostic tests could face increased federal enforcement following a recent report by the HHS Office of the Inspector General.
You may also be interested in...
Comfrey
FTC action July 13 against comfrey marketer Western Botanicals (Fair Oaks, Calif.) is second one in two weeks. Decision is part of commission's "Operation Cure.All" crackdown on unsupported supplement claims. Stipulated permanent injunction bars defendant from future sale of internal comfrey products, external products without warnings; Western also is required to notify distributors, purchasers by mail. FDA issued a comfrey advisory July 6 following FTC action against comfrey supplement marketer Christopher Enterprises (1"The Tan Sheet" July 9, p. 10). Several trade groups have voiced support for comfrey actions and pointed to voluntary label programs already in place
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands